these results suggest that the elevation of plasma 6-keto-pgf1 alpha by captopril therapy was not responsible for reducing blood pressure , while enhanced plasma prostacyclin as a chronic response may contribute to prevention of thrombotic disorders and organ damage .
C0006938
captopril
C0020649
reducing blood pressure